Perampanel CIII Tablets, 6mg recall — Sun Pharmaceutical Industries Inc (Class II)

Sun Pharmaceutical Industries Inc is recorded by the U.S. Food and Drug Administration (FDA) as recalling Perampanel CIII Tablets, 6mg — a Class II recall, initiated 2026-06-17 and posted to the FDA enforcement report on 2026-07-01, under recall number D-0628-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.”. From the product description, the form is tablets, the strength given is 6mg, the package is described as 30 Tablets and it is marked Rx only. 1 National Drug Code number is printed in the record: 51672-4206-6. Distribution is recorded as “Nationwide in the USA” — Nationwide (US), with the recalling firm on record in NJ, United States. It is the only recall number the FDA has filed under event ID 99256. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0628-2026
FDA event ID 99256
Classification Class II (intermediate regulatory tier)
Status Ongoing
Recalling firm Sun Pharmaceutical Industries Inc
Recall initiated 2026-06-17
Reported by FDA 2026-07-01
Report lag 14 days from initiation to report
Distribution Nationwide in the USA — Nationwide (US)
Firm location on record NJ, United States
Product description (source) Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6

Reason reported by FDA

Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.

19 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

5 identifying values matched by exact pattern in the 28-word product description above; each is a literal substring of it.

Product named Perampanel CIII Tablets
Form Tablets
Strength 6mg
Package 30 Tablets
NDC 51672-4206-6
Marketing category Rx only

Other indexed recalls from Sun Pharmaceutical Industries Inc

6 indexed records name Sun Pharmaceutical Industries Inc as the recalling firm, across 5 FDA events, reported 2026-06-10 to 2026-07-08. A coverage-limited activity count over the ingested window, not a quality rating.

Recall recordRecall numberFDA tierStrength / formReported
Fexofenadine Hydrochloride Tablets, 180 mgD-0654-2026Class III180 mg · Tablets2026-07-08
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mLD-0580-2026Class I50 mg/25 mL · Injection2026-06-17
Budesonide Inhalation Suspension, 1mg/2mLD-0607-2026Class II1mg/2mL · Suspension2026-06-17
Xyvona (levorphanol tartrate tablets), 2mgD-0598-2026Class II2mg · Tablets2026-06-10
Xyvona (levorphanol tartrate tablets), 3mgD-0599-2026Class II3mg · Tablets2026-06-10

Reported in the same month (2026-07)

111 enforcement reports carry a report date in 2026-07; these 8 are the Class II ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
MAJOR, 0.2 mgD-0609-2026The Harvard Drug Group LLCClass II2026-07-01
Fenofibrate Capsules, 200 mgD-0611-2026Ajanta Pharma Usa IncClass II2026-07-01
Corlanor (ivabradine) tablets, 5 mgD-0612-2026Amgen, Inc.Class II2026-07-01
Sensipar (cinacalcet) Tablets, 30mgD-0613-2026Amgen, Inc.Class II2026-07-01
Sensipar (cinacalcet) Tablets, 60mgD-0614-2026Amgen, Inc.Class II2026-07-01
Corlanor (ivabradine) tablets, 7.5mgD-0615-2026Amgen, Inc.Class II2026-07-01
Sensipar (cinacalcet) Tablets, 90mgD-0616-2026Amgen, Inc.Class II2026-07-01
DULOXETINE D/R, 30 mgD-0617-2026Direct RXClass II2026-07-01

Nearest Class II recalls by date

213 of 250 indexed records share the Class II tier; the 3 nearest to 2026-07-01 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, 1295 mLD-0618-2026Central Admixture Pharmacy Services, Inc.1295 mL · Injection2026-07-01
PReye Vitamin See Antioxidant Preservative Free Eye DropsD-0621-2026Preye LLCEye Drops2026-07-01
BD ChloraPrep Clear, 2%D-0622-2026Carefusion 213, LLC2% · Solution2026-07-01

Reading this record

Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 51672-4206-6 at the FDA source to confirm it is covered.

Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Sun Pharmaceutical Industries Inc (6 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0628-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0628-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-07-01
Ingested
2026-08-22
Record hash
36b92e3c3c3110c3

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.